Champ-Rigot L, Cornille AL, Ollitrault P, et al. – In this study involving patients older and younger than 75 years of age, researchers determined if predictive factors for cardiac resynchronization therapy outcomes vary. They retrospectively included consecutive patients who received a cardiac resynchronization device cardiac resynchronization therapy between 2013 and 2016. Of the 243 participants, 102 were ≥ 75 years old. In all, cardiac resynchronization therapy response was not compromised by patient age at 1 year. In older patients, highly symptomatic individuals with NYHA class III or greater demonstrated better outcomes following cardiac resynchronization therapy.